Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis

Life Sciences

Volumn 93, Issue 8, 2013, Pages 307-312

  Riegsecker, Sharayah ^a   Wiczynski, Dustin ^a   Kaplan, Mariana J ^b   Ahmed, Salahuddin ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular dysfunction; EGCG; Rheumatoid arthritis; Synovial inflammation; Systemic inflammation

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BEZAFIBRATE; CIPROFIBRATE; CLOFIBRATE; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; EPIGALLOCATECHIN GALLATE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; GREEN TEA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; POLYPHENOL; RESVERATROL; ROFECOXIB; TRIPTERYGIUM WILFORDII EXTRACT; TRIPTOLIDE; WITHANOLIDE;

ACUTE HEART INFARCTION; ALLERGIC ENCEPHALOMYELITIS; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; BONE DESTRUCTION; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG TARGETING; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL IRRITATION; GINSENG; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; OSTEOARTHRITIS; PAIN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM; TEA; THROMBOEMBOLISM; VASCULITIS;

CARDIOVASCULAR DYSFUNCTION; EGCG; RHEUMATOID ARTHRITIS; SYNOVIAL INFLAMMATION; SYSTEMIC INFLAMMATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CATECHIN; COMPLEMENTARY THERAPIES; CYTOKINES; HUMANS; INFLAMMATION; TEA;

ANIMALIA;

EID: 84883217899     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.07.006     Document Type: Review

References (66)

1. C. Adcocks, P. Collin, and D.J. Buttle Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage proteoglycan and type II collagen degradation in vitro J Nutr 132 2002 341 346
2. B.B. Aggarwal, and S. Shishodia Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning Ann N Y Acad Sci 1030 2004 434 441
3. S. Ahmed Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise Arthritis Res Ther 12 2010 208
4. S. Ahmed, A. Rahman, A. Hasnain, M. Lalonde, V.M. Goldberg, and T.M. Haqqi Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes Free Radic Biol Med 33 2002 1097 1105
5. S. Ahmed, A. Pakozdi, and A.E. Koch Regulation of interleukin-1beta- induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts Arthritis Rheum 54 2006 2393 2401
6. S. Ahmed, H. Marotte, K. Kwan, J.H. Ruth, P.L. Campbell, and B.J. Rabquer Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production Proc Natl Acad Sci U S A 105 2008 14692 14697
7. S. Ahmed, M.D. Silverman, H. Marotte, K. Kwan, N. Matuszczak, and A.E. Koch Down-regulation of myeloid cell leukemia 1 by epigallocatechin-3-gallate sensitizes rheumatoid arthritis synovial fibroblasts to tumor necrosis factor alpha-induced apoptosis Arthritis Rheum 60 2009 1282 1293
8. N. Akhtar, and T.M. Haqqi Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes Arthritis Res Ther 13 2011 R93
9. O. Aktas, T. Prozorovski, A. Smorodchenko, N.E. Savaskan, R. Lauster, and P.M. Kloetzel Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis J Immunol 173 2004 5794 5800
10. P. Alagona Jr. Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia Vasc Health Risk Manag 6 2010 351 362
11. R. Aneja, P.W. Hake, T.J. Burroughs, A.G. Denenberg, H.R. Wong, and B. Zingarelli Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats Mol Med 10 2004 55 62
12. F. Atzeni, M. Turiel, R. Caporali, L. Cavagna, L. Tomasoni, and S. Sitia The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases Autoimmun Rev 9 2010 835 839
13. L.F. Callahan, E.K. Wiley-Exley, T.J. Mielenz, T.J. Brady, C. Xiao, and S.S. Currey Use of complementary and alternative medicine among patients with arthritis Prev Chronic Dis 6 2009 A44
14. S. Chen, T.R. Crother, and M. Arditi Emerging role of IL-17 in atherosclerosis J Innate Immun 2 2010 325 333
15. H.K. Choi, M.A. Hernan, J.D. Seeger, J.M. Robins, and F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
16. Y. Clement Can green tea do that? A literature review of the clinical evidence Prev Med 49 2009 83 87
17. J. Fan, and T. Watanabe Inflammatory reactions in the pathogenesis of atherosclerosis J Atheroscler Thromb 10 2003 63 71
18. L. Ferrero-Miliani, O.H. Nielsen, P.S. Andersen, and S.E. Girardin Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation Clin Exp Immunol 147 2007 227 235
19. S.E. Gabriel Heart disease and rheumatoid arthritis: understanding the risks Ann Rheum Dis 69 Suppl. 1 2010 i61 i64
20. R. Goldbach-Mansky, M. Wilson, R. Fleischmann, N. Olsen, J. Silverfield, and P. Kempf Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial Ann Intern Med 151 2009 229 240
21. A. Gupta, and B. Fomberstein Evaluating cardiovascular risk in rheumatoid arthritis J Musculoskeletal Med. 26 2009 301 304
22. J. Hao, C.H. Kim, T.S. Ha, and H.Y. Ahn Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats J Vet Sci 8 2007 121 129
23. Y. Haruna, Y. Morita, T. Yada, M. Satoh, D.A. Fox, and N. Kashihara Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis Arthritis Rheum 56 2007 1827 1835
24. C. Hayashi, A.G. Madrigal, X. Liu, T. Ukai, S. Goswami, and C.V. Gudino Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses J Innate Immun 2 2010 334 343
25. K.B. Hoffman, C. Kraus, M. Dimbil, and B.A. Golomb A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class PLoS One 7 2012 e42866
26. H. Ichikawa, Y. Takada, S. Shishodia, B. Jayaprakasam, M.G. Nair, and B.B. Aggarwal Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regulated gene expression Mol Cancer Ther 5 2006 1434 1445
27. M. Kamon, R. Zhao, and K. Sakamoto Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells Cell Biol Int 34 2010 109 116
28. M.J. Kaplan Management of cardiovascular disease risk in chronic inflammatory disorders Nat Rev Rheumatol 5 2009 208 217
29. N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate Cancer Res 66 2006 2500 2505
30. D. Khanna, G. Sethi, K.S. Ahn, M.K. Pandey, A.B. Kunnumakkara, and B. Sung Natural products as a gold mine for arthritis treatment Curr Opin Pharmacol 7 2007 344 351
31. I.B. Kim, D.Y. Kim, S.J. Lee, M.J. Sun, M.S. Lee, and H. Li Inhibition of IL-8 production by green tea polyphenols in human nasal fibroblasts and A549 epithelial cells Biol Pharm Bull 29 2006 1120 1125
32. Y. Kumeda, M. Inaba, H. Goto, M. Nagata, Y. Henmi, and Y. Furumitsu Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis Arthritis Rheum 46 2002 1489 1497
33. N. Kusunoki, R. Yamazaki, H. Kitasato, M. Beppu, H. Aoki, and S. Kawai Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts BMC Pharmacol 4 2004 2
34. J.H. Lee, H. Jin, H.E. Shim, H.N. Kim, H. Ha, and Z.H. Lee Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal Mol Pharmacol 77 2010 17 25
35. S.K. Lin, H.H. Chang, Y.J. Chen, C.C. Wang, D.L. Galson, and C.Y. Hong Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis Arthritis Rheum 58 2008 3145 3156
36. J. Listing, A. Strangfeld, J. Kekow, M. Schneider, A. Kapelle, and S. Wassenberg Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? Arthritis Rheum 58 2008 667 677
37. D. Liu, P. Li, S. Song, Y. Liu, Q. Wang, and Y. Chang Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis Eur J Pharmacol 690 2012 214 225
38. M. Lorenz, S. Wessler, E. Follmann, W. Michaelis, T. Dusterhoft, and G. Baumann A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation J Biol Chem 279 2004 6190 6195
39. A. Ludwig, M. Lorenz, N. Grimbo, F. Steinle, S. Meiners, and C. Bartsch The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells Biochem Biophys Res Commun 316 2004 659 665
40. A.R. Meki, E.A. Hamed, and K.A. Ezam Effect of green tea extract and vitamin C on oxidant or antioxidant status of rheumatoid arthritis rat model India J Clin Biochem 24 2009 280 287
41. G.S. Metsios, A. Stavropoulos-Kalinoglou, A. Sandoo, J.J. van Zanten, T.E. Toms, and H. John Vascular function and inflammation in rheumatoid arthritis: the role of physical activity Open Cardiovasc Med J 4 2010 89 96
42. Y. Miura, T. Chiba, I. Tomita, H. Koizumi, S. Miura, and K. Umegaki Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice J Nutr 131 2001 27 32
43. A. Morinobu, W. Biao, S. Tanaka, M. Horiuchi, L. Jun, and G. Tsuji (-)-Epigallocatechin-3-gallate suppresses osteoclast differentiation and ameliorates experimental arthritis in mice Arthritis Rheum 58 2008 2012 2018
44. A. Morrison, D.R. Ramey, J. van Adelsberg, and D.J. Watson Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension Curr Med Res Opin 23 2007 2395 2404
45. K.J. Mukamal, M. Maclure, J.E. Muller, J.B. Sherwood, and M.A. Mittleman Tea consumption and mortality after acute myocardial infarction Circulation 105 2002 2476 2481
46. V.F. Panoulas, G.S. Metsios, A.V. Pace, H. John, G.J. Treharne, and M.J. Banks Hypertension in rheumatoid arthritis Rheumatology 47 2008 1286 1298
47. C.S. Piao, D.S. Kim, K.C. Ha, H.R. Kim, H.J. Chae, and S.W. Chae The protective effect of epigallocatechin-3 gallate on ischemia/reperfusion injury in isolated rat hearts: an ex vivo approach Korean J Physiol Pharmacol 15 2011 259 266
48. M. Pirotta Arthritis disease - the use of complementary therapies Aust Fam Physician 39 2010 638 640
49. E. Ramesh, P. Geraldine, and P.A. Thomas Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis Chem Biol Interact 183 2010 125 132
50. P.M. Ridker, and D.H. Solomon Should patients with rheumatoid arthritis receive statin therapy? Arthritis Rheum 60 2009 1205 1209
51. S.H. Roth Coming to terms with nonsteroidal anti-inflammatory drug gastropathy Drugs 72 2012 873 879
52. L. Semerano, G. Clavel, E. Assier, A. Denys, and M.C. Boissier Blood vessels, a potential therapeutic target in rheumatoid arthritis? Joint Bone Spine 78 2011 118 123
53. C.L. Shen, B.J. Smith, D.F. Lo, M.C. Chyu, D.M. Dunn, and C.H. Chen Dietary polyphenols and mechanisms of osteoarthritis J Nutr Biochem 23 2012 1367 1377
54. S.M. Shenouda, and J.A. Vita Effects of flavonoid-containing beverages and EGCG on endothelial function J Am Coll Nutr 26 2007 366S 372S
55. R. Singh, S. Ahmed, N. Islam, V.M. Goldberg, and T.M. Haqqi Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB Arthritis Rheum 46 2002 2079 2086
56. R. Singh, S. Ahmed, C.J. Malemud, V.M. Goldberg, and T.M. Haqqi Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes J Orthop Res 21 2003 102 109
57. B.N. Singh, S. Shankar, and R.K. Srivastava Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications Biochem Pharmacol 82 2011 1807 1821
58. K. Takayama, K. Ishida, T. Matsushita, N. Fujita, S. Hayashi, and K. Sasaki SIRT1 regulation of apoptosis of human chondrocytes Arthritis Rheum 60 2009 2731 2740
59. Y. Tang, I. Matsuoka, T. Ono, K. Inoue, and J. Kimura Selective up-regulation of P2X4-receptor gene expression by interferon-gamma in vascular endothelial cells J Pharmacol Sci 107 2008 419 427
60. V.P. van Halm, M.T. Nurmohamed, J.W. Twisk, B.A. Dijkmans, and A.E. Voskuyl Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study Arthritis Res Ther 8 2006 R151
61. O. Weinreb, T. Amit, S. Mandel, and M.B. Youdim Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties Genes Nutr 4 2009 283 296
62. M.E. Widlansky, N.M. Hamburg, E. Anter, M. Holbrook, D.F. Kahn, and J.G. Elliott Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease J Am Coll Nutr 26 2007 95 102
63. D. Wu, J. Wang, M. Pae, and S.N. Meydani Green tea EGCG, T cells, and T cell-mediated autoimmune diseases Mol Aspects Med 33 2012 107 118
64. C.J. Xian, and X.F. Zhou Treating skeletal pain: limitations of conventional anti-inflammatory drugs, and anti-neurotrophic factor as a possible alternative Nat Clin Pract 5 2009 92 98
65. H.J. Yun, W.H. Yoo, M.K. Han, Y.R. Lee, J.S. Kim, and S.I. Lee Epigallocatechin-3-gallate suppresses TNF-alpha -induced production of MMP-1 and -3 in rheumatoid arthritis synovial fibroblasts Rheumatol Int 29 2008 23 29
66. H. Zhang, Y. Park, J. Wu, X. Chen, S. Lee, and J. Yang Role of TNF-alpha in vascular dysfunction Clin Sci 116 2009 219 230